Introduction: The Octreotide Sameness Study for ANDA submission is a critical regulatory requirement when filing a generic octreotide product with […]
Case Study: Sameness Evaluation of Octreotide Generic project submission to USFDA Read More »
Introduction: The Liraglutide Sameness Study for ANDA submission is a critical regulatory requirement when filing a generic version of liraglutide
Case Study: Sameness Evaluation of Liraglutide Generic project submission to USFDA Read More »
Introduction: Choosing the Best CRO for Peptide Sameness Study is one of the most critical strategic decisions in a generic
CRO Checklist: How to Select the Best Lab for Peptide Sameness Study Read More »
Introduction: Peptide Sameness Study Deficiencies are a leading cause of regulatory delays during ANDA review for generic peptide products. When
Common Deficiencies in Peptide Sameness Study During ANDA Review Read More »
Introduction: Peptide Sequencing and Mapping for Sameness Study is the foundation for demonstrating structural identity between a generic peptide drug
Introduction: FDA Peptide Sameness Study Requirements define the scientific and regulatory framework needed to demonstrate that a generic synthetic peptide
Regulatory Requirements for Peptide Sameness Study (FDA & Health Canada) Read More »
Introduction: Why Nitrosamine Testing Highly Potent APIs Requires Specialized Expertise Nitrosamine Testing Highly Potent APIs demands highly sensitive analytical methods,
Nitrosamine Testing in Controlled Substances and Highly Potent APIs (HPAPIs) Read More »
Introduction: Applying a Nitrosamine Reformulation Strategy Without Compromising Bioequivalence A structured Nitrosamine Reformulation Strategy can block nitrosamine formation pathways while
Introduction: Peptide Sameness vs Biosimilar Comparability is one of the most misunderstood concepts in modern pharmaceutical development. While both involve
Peptide Sameness Study vs Biosimilar Comparability: What’s the Difference? Read More »
Introduction In this NDMA Root Cause Investigation Case Study, we examine a real-world scenario involving an unexpected spike of N-nitrosodimethylamine
Case Study: Root Cause Investigation of Unexpected NDMA Spike in Finished Product Read More »
